# Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer

> **NCT01712893** · PHASE3 · COMPLETED · sponsor: **Fudan University** · enrollment: 216 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Zoladex

## Key facts

- **NCT ID:** NCT01712893
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2017-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01712893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01712893, "Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01712893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*